U.S. Food and Drug Administration Coronavirus COVID-19 Update - - - December 16, 2020

U.S. Food and Drug Administration Coronavirus (COVID-19) Update: December 16, 2020 | site |


(Information contained in U.S. Food and Drug Administration [FDA] press release dated: December 16, 2020)

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:

• Today, the FDA issued a new Emergency Use Authorization (EUA) for the BinaxNOW COVID-19 Ag Card Home Test for at-home use with a prescription. The BinaxNOW COVID-19 Ag Card Home Test is an antigen test that detects fragments of proteins from SARS-CoV-2, the virus that causes COVID-19, from a nasal swab sample. It is authorized for use at home with self-collected samples in individuals age 15 years or older who are suspected of having COVID-19 by a health care provider within the first seven days of symptom onset. The test is also for use with individuals aged four years or older who

...

U.S. Food and Drug Administration Coronavirus (COVID-19) Update: November 16, 2020 | site |



(November 16, 2020) - - The U.S. Food and Drug Administration (FDA) published (today) the following information:

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:

• Today, FDA updated its guidance on investigational COVID-19 convalescent plasma. The updated guidance extends the period of enforcement discretion through the end of February 2021. This extension will allow continued access to convalescent plasma for the treatment of hospitalized COVID-19 patients while blood establishments develop the necessary operating procedures to manufacture the plasma consistent with the EUA. The guidance also includes a new recommendation that authorized COVID-19 convalescent plasma not be collected from individuals who have received an investigational COVID-19 vaccine.

• The agency

...

World Health Organization February 16, 2020 Update on COVID-19 in the Eastern Mediterranean Region| site |




(February 16, 2020) - - Today (February 16, 2020), the World Health Organization (WHO) published the following information: Cairo, Egypt, 16 February, 2020 - The World Health Organization announces a total of nine confirmed cases of COVID-19 in the Eastern Mediterranean Region as of 16 February 2020. Eight cases were reported in by the United Arab Emirates Ministry of Health and Prevention between 29 January and 9 February, and one case was reported by the Egyptian Ministry of Health and Population on 14 February. The Ministry of Health and Prevention of the United Arab Emirates has reported that 3 COVID-2019 cases have fully recovered and were released from hospital on 9 and 14 February. The confirmed case in Egypt is asymptomatic and was identified through contact screening of an index case who travelled to Cairo between 21 January and 4 Feb...